Investor Relations Manager

Kiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immunology and inflammation, Kiniksa is advancing a growing portfolio of approved and investigational medicines, anchored by its lead product, ARCALYST®, the first and only FDA‑approved therapy for recurrent pericarditis. Grounded in rigorous science and bold innovation, the company fosters a highly collaborative, patient‑first culture led by accomplished life sciences leaders. At Kiniksa, talented individuals are trusted and empowered to make a real impact—shaping the future of medicine while improving the lives of patients who need it most.

Kiniksa Pharmaceuticals is seeking a Manager of Investor Relations, reporting to the Director of Investor Relations. The Manager of Investor Relations will serve as a core contributor across significant recurring Investor Relations workstreams, including materials development, investor analytics, sell-side engagement, and stakeholder communications. This role will collaborate internally with a team that includes clinical, commercial, finance, marketing, and legal functions to help develop and communicate Kiniksa’s business principles, corporate vision, financial performance, and value creation strategy.

This role is based in our Lexington office and requires an onsite presence five days per week to support our commitment to seamless partnership, timely decision-making, and high-impact execution.

Responsibilities (including, but not limited to):

• Contribute to the implementation of an IR program that is aligned with the company’s strategy and goals;
• Support message development aimed at educating the capital markets on Kiniksa’s corporate strategy, execution, opportunity set, and potential risks;
• Assist in the preparation and maintenance of core messaging materials, including investor presentations, press releases, call scripts, and Q&A documents;
• Monitor sell-side consensus and analyze individual equity research models and valuation frameworks among Kiniksa’s covering analysts;
• Track and provide feedback on changes to the shareholder base, investor sentiment, peer performance, and capital markets trends;
• Research and maintain a prioritized institutional investor target list, including investment style profiling, contact prioritization and tracking, and CRM management;
• Track investor interactions and prepare executive-level briefing materials for key spokespeople in support of a high impact calendar (e.g., investor conferences and roadshows, scientific/medical meetings, quarterly earnings, etc.);
• Manage relationships and workstreams with third-party service providers;